Page last updated: 2024-08-21

benzylideneacetone and Acute Lung Injury

benzylideneacetone has been researched along with Acute Lung Injury in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, W; Deng, JS; Huang, GJ; Huang, SS; Li, PY; Liang, YC1

Other Studies

1 other study(ies) available for benzylideneacetone and Acute Lung Injury

ArticleYear
3, 4-dihydroxybenzalacetone attenuates lipopolysaccharide-induced inflammation in acute lung injury via down-regulation of MMP-2 and MMP-9 activities through suppressing ROS-mediated MAPK and PI3K/AKT signaling pathways.
    International immunopharmacology, 2017, Volume: 50

    Topics: Acute Lung Injury; Animals; Butanones; Cytokines; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred ICR; Nitric Oxide; Phellinus; Phosphatidylinositol 3-Kinases; Plant Extracts; Pneumonia; Reactive Oxygen Species; Signal Transduction

2017